Please log in to view this page
Username
Password
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...
